Moreover, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibition, a critical enzyme for cholesterol biosynthesis, led to an increase in glycolysis via regulated HSP90 expression levels, inducing tumor growth acceleration [72]. The gene discussed is HSP90AA1; the disease is neoplasm.